|
|
|
Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.
Home > Health Conditions > Lymphoma
Non-Hodgkin's Lymphoma
Popular Supplements:
Alternative News:
-
Leukemia
and Lymphoma (Hodgkin's and Non-Hodgkin's Disease) - Life Extension Foundation
-
Curcumin
induces cell-arrest and apoptosis in association with the inhibition of
constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma
cells - Int J Cancer. 2008 Apr 3 -
"Interestingly, curcumin caused cell cycle arrest in G2-M and a significant
reduction (80-97%) in H-RS cell viability. Furthermore, curcumin triggered
cell death by apoptosis, as evidenced by the activation of caspase-3 and
caspase-9, changes in nuclear morphology and phosphatidylserine
translocation. The above findings provide a mechanistic rationale for the
potential use of curcumin as a therapeutic agent for patients with HL"
- See
Curcumin/turmeric products at iHerb
 .
-
Vegetables- and antioxidant-related nutrients, genetic susceptibility, and
non-Hodgkin lymphoma risk - Cancer Causes Control. 2008 Jan 17 -
"For the GSTM3 3-base insertion and higher total
vegetable intake, the risk was 0.56 (0.35-0.92, p interaction = 0.03); for
GSTP1 A114V and higher cruciferous vegetable intake, the risk was 0.52
(0.34-0.81, p interaction = 0.02); for OGG1 S326C and higher daily zinc
intake, the risk was 0.71 (0.47-1.08, p interaction = 0.04) and for XRCC3
T241M and higher green leafy vegetable intake, the risk was 0.63"
-
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin
lymphoma - Cancer Causes Control. 2007 Jul 25 -
"Our results suggest that the inverse association between UV exposure and
NHL risk may be mediated by the vitamin D pathway"
-
Carotenoids linked to lower risk of non-Hodgkin lymphoma - Nutra USA,
6/12/06 - "High daily intakes of the
carotenoids lutein and zeaxanthin, as well as vegetables in general, could
reduce the risk of non-Hodgkin lymphoma by almost 50 per cent"
-
Getting Some Sun May Fight Blood Cancer - WebMD, 3/31/04 -
"women and men who got the most sun exposure during their off-work hours had the lowest risk
of non-Hodgkin's lymphoma ... What might be causing it? The obvious answer is that vitamin D synthesized in the skin from sun exposure is causing this effect. There is increasing evidence that vitamin D has protective effects against many cancers. The evidence for colorectal cancer protection is pretty solid"
- Diet Linked to Non-Hodgkin's Lymphoma - WebMD, 3/9/04 -
"if a person has a higher intake of animal protein, they will have a higher risk of
non-Hodgkin's lymphoma ... And people who have a higher intake of saturated fat have an increased risk. On the other hand, if you have higher-than-average intake of dietary fiber -- particularly if you frequently eat vegetables and fruits with a high fiber content -- you have a reduced risk of non-Hodgkin's
lymphoma"
-
What
role, if any, does Cox-2 inhibition play in the case of lymphoma? - Life Extension Magazine, 1/02
-
Fish
Oil Slows Lymphoma - Life Extension Magazine, 9/00
CME:
General Information:
-
Lymphoma - American Academy of Family Physicians
- Lymphoma - emedicine.com
-
Lymphoma - FamilyDoctor.org
- Lymphoma - Intelihealth
- Lymphoma - Merck
- favrille.com - Clinical trials on lymphoma vaccine
- Lymphoma - Non-Hodgkin's Lymphoma - Veritas Medicine
- Lymphoma - Veritas Medicine
- Treatments for lymphoma
 - Medifocus.com
Other News:
-
New
Treatment Approach Promising For Lymphoma Patients In Developing World -
Science Daily, 7/6/08
-
Watch-And-Wait Strategy
Appropriate in Many With Residual MALT Lymphoma - Medscape, 1/1/08
-
Mini-BMT: Non-Hodgkin's Lymphoma Cure? - WebMD, 12/10/07
-
A New Resource for Lymphoma Patients - Physician's Weekly, 10/15/07
-
Lymphoma Drug Bexxar Effective Over Long Term, Study Finds - Science
Daily, 6/4/07
-
Risk
Of Lymphoma Increases With Hepatitis C Virus Infection - Science Daily,
5/8/07
-
Promising Results For Patients With Aggressive, Recurrent Non-Hodgkin
Lymphoma Using New Oral Drug - Science Daily, 12/19/06
-
FDA Approves Velcade(R) (Bortezomib) for Injection for Aggressive Form of
Non-Hodgkin's Lymphoma - Doctor's Guide, 12/8/06
-
New Hope for Patients With Chronic Lymphocytic Leukemia - Doctor's
Guide, 12/5/06
-
Personalized Cancer Vaccine Improves Disease Free Survival - Doctor's
Guide, 10/20/06 - "administration of
the BiovaxID™ anti-cancer vaccine formulation resulted in long-lasting
remission in NHL patients"
-
Allos Therapeutics Receives FDA Fast Track Designation for PDX for the
Treatment of T-cell Lymphoma - Doctor's Guide, 10/3/06
-
FDA Approves Two New Indications for Rituxan(R) (Rituximab) in Patients With
Non-Hodgkin's Lymphoma - Doctor's Guide, 9/30/06
-
Custom-Made Lymphoma Vaccine Promising - WebMD, 9/19/06
-
FDA Grants Orphan Drug Designation to Allos Therapeutics' Novel Antifolate
PDX (Pralatrexate) for Treatment of T-cell Lymphoma - Doctor's Guide,
7/26/06
-
One-Third of Patients With Mantle Cell Lymphoma Respond to Bortezomib
Treatment - Doctor's Guide, 6/6/06
-
Primary Intraocular Lymphoma Patients Respond to Methotrexate Therapy -
Doctor's Guide, 5/5/06
-
Pixantrone Combination Regimen Produces High Rates of Complete Remission for
Patients With Aggressive NHL Who Fail CHOP Therapy - Doctor's Guide,
3/22/06
-
FDA Approves Rituxan (Rituximab) Plus CHOP or Other Anthracycline-Based
Chemotherapy Regimens for First-Line Treatment of Diffuse Large B-cell
Non-Hodgkin's Lymphoma - Doctor's Guide, 2/13/06
-
BiovaxID Yields 89% Survival in Patients with Aggressive Non-Hodgkin's -
Doctor's Guide, 1/24/06
-
BiovaxID Produces Long Term Clinical Remission and 95% Overall Survival
- Doctor's Guide, 1/11/06
-
Zevalin Used in Abbreviated Chemotherapy Regimen Shows Efficacy for
Follicular Non-Hodgkin's Lymphoma - Doctor's Guide, 12/16/05
-
New Treatment Regimen May Improve Mantle Cell Lymphoma - Doctor's Guide,
12/14/05
-
Total Body Irradiation Followed by Autologous Stem Cell Transplantation Best
Option for Chemo-Resistant Hodgkin's Lymphoma - Doctor's Guide, 12/13/05
-
Age Makes Little Difference in Outcomes for Non-Hodgkin's Lymphoma Patients
Receiving Chemotherapy - Doctor's Guide, 12/12/05
-
PCBs, Furans May Factor In Risk Of Non-Hodgkin Lymphoma - Science Daily,
12/2/05
-
Addition of Pixantrone to Rituxan Therapy Significantly Prolongs Time to
Disease Progression and Improves the Overall Response Rate Compared to
Rituxan Alone in Relapsed or Refractory Indolent Lymphoma - Doctor's
Guide, 11/9/05
-
Yttrium 90 Ibritumomab Tiuxetan (Zevalin) as Effective in Older as in
Younger Non-Hodgkin's Lymphoma Patients - Doctor's Guide, 10/24/05
-
Treatment Advances For Lymphoma Have Reduced Deaths By 70% - Science
Daily, 10/21/05
-
Treatment Advances for Lymphoma Have Reduced Deaths By 70% - Doctor's
Guide, 10/20/05
-
Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody
Effective in Previously Untreated Non-Hodgkin 's Lymphoma - Doctor's
Guide, 9/9/05
-
Tositumomab and Iodine I-131 Tositumomab May Result in Prolonged Remission
in Low-Grade NHL - Medscape, 6/22/05
-
Positive Effects of Nuclear Medicine, 'Smart Drugs' Provide Hope for
Non-Hodgkin's Lymphoma Patients - Doctor's Guide, 6/21/05
-
High-Dose Methotrexate for Elderly Patients With Newly Diagnosed Primary
Central Nervous System Lymphoma - Doctor's Guide,
6/17/05
-
Addition of Rituximab to Combination Chemotherapy Improves Outcomes in
Advanced Stage Lymphoplasmocytoid/ic Immunocytoma -
Doctor's Guide, 6/15/05
-
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) Induces High Response Rates in
Previously Treated Patients With Diffuse Large B-Cell Lymphoma - Doctor's Guide, 6/14/05
-
Limited Stage Follicular Lymphoma Might Be Curable: Presented at ICML -
Doctor's Guide, 6/13/05
-
Fludarabine Offers Option for First-Line Treatment of Chronic Lymphocytic
Lymphoma - Doctor's Guide, 6/10/05
-
Low-Dose Involved Field Radiotherapy Induces Rapid and Lasting Remissions
Without Significant Toxicity in B-Cell Lymphoma -
Doctor's Guide, 6/10/05
-
New Regimen After Chemotherapy Improves Survival in Elderly Patients With
Diffuse Large-Cell Lymphoma - Doctor's Guide, 6/10/05
-
Pegylated Liposomal Doxorubicin (Caelyx)-Based Regimen Carries Less Cardiac
Toxicity: Presented at ESMO - Doctor's Guide, 6/9/05
-
Less Aggressive Regimen As Effective and Equally Tolerated as Standard
Treatment for Elderly Patients With Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 6/9/05
-
Large Study Shows Link Between Statin Use and Risk of Lymphoma - Doctor's Guide, 6/9/05 -
"Use of statins is associated with a decrease in the risk of developing any
type of lymphoma"
-
Bortezomib Shows Promise in Treatment of Relapsed or Refractory Mantle Cell
Lymphoma - Doctor's Guide, 6/9/05
-
Rituximab Improves Outcomes in Patients With Diffuse Large B-Cell Lymphoma - Doctor's Guide, 6/8/05
-
Rituximab Plus CVP Versus CVP Alone Improves Outcomes in First-Line
Treatment of Advanced Follicular Lymphoma - Doctor's
Guide, 6/8/05
-
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) Therapy With Rituximab Maintenance
Might Improve Outcomes in Patients With Low-Grade Follicular Lymphoma - Doctor's Guide, 6/8/05
-
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma -
N Engl J Med. 2005 Mar 24;352(12):1197-205
-
HuMax-CD4 (Zanolimumab) Shows Long-Lasting Responses in T-Cell Lymphoma Patients - Doctor's Guide, 2/18/05
- New Treatment Rivals Chemotherapy For Lymphoma, Study Finds - Science Daily, 2/8/05
- 'Zapping' Cancer - CBS 2 Chicago, 2/3/05
- New Non-Hodgkin's Lymphoma Drug Passes Hurdle - WebMD, 2/2/05
- FDA Approves Expanded Indication for Bexxar (Tositumomab) in Non-Hodgkin's Lymphoma - Doctor's Guide, 1/3/05
- New Therapeutic Strategies for Non-Hodgkin's Lymphoma: An Expert Interview With Dr. Richard Fisher - Medscape, 12/20/04
- Breakthrough MabThera data now shows patients with indolent Non-Hodgkin's Lymphoma can live longer - Doctor's Guide, 12/10/04
- Bortezomib Combats Non-Hodgkin's Lymphomas - Doctor's Guide, 12/8/04
- Rituximab Standard Therapy Effective for Many Non-Hodgkin's Lymphomas - Doctor's Guide, 12/6/04
- Blood Test May Reveal Lymphoma Dangers - WebMD, 11/17/04
- FDA Grants Fast Track Status to Velcade (bortezomib) for Injection for Relapsed and Refractory Mantle Cell Lymphoma - Doctor's Guide, 11/3/04
- Half of Patients With Aggressive Non-Hodgkin's Lymphoma May Not Receive Full Recommended Dose of Chemotherapy - Doctor's Guide, 9/21/04
- Prolonged Rituximab Shows Promise for Follicular Lymphoma and Mantle Cell Leukemia - Doctor's Guide, 9/16/04
- Maintenance Rituximab May Prolong Progression-Free Survival and Response Rates in Previously Untreated Follicular Lymphoma - Doctor's Guide, 9/15/04
- Rituximab Provides Additional Benefits to Initial Chemotherapy in Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 9/15/04
- Rituximab Adds Efficacy to Aggressive Chemotherapy Regimen for HIV Patients With Non-Hodgkin's Lymphoma - Doctor's Guide, 9/15/04
- Addition of Rituximab Improves Outcomes Over Standard Immunochemotherapy in Follicular Lymphoma - Doctor's Guide, 9/15/04
- Single-agent Rituximab May Prove Effective and Safe for Chronic Thrombocytopenia Purpura - Doctor's Guide, 9/15/04
- Rituximab Provides Effective Rescue Treatment for Patients With Refractory Immune Thrombocytopenia Purpura - Doctor's Guide, 9/14/04
- EPOCH Regimen Plus Rituximab Effective and Well Tolerated for Aggressive Diffuse Large B-cell and Mantle Cell Lymphoma - Doctor's Guide, 9/14/04
- Rituximab Improves Efficacy of Fludarabine-Based Therapy in Chronic Lymphocytic Leukemia - Doctor's Guide, 9/14/04
- Improved Overall Survival Rates Seen With Combined Immunochemotherapy Approach in Indolent Non-Hodgkin's Lymphoma - Doctor's Guide, 9/13/04
- Intrathecal Administration of Rituximab Shows Promise for Central Nervous System Lymphoma - Doctor's Guide, 9/13/04
- Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation Improves Survival in Mantle Cell Lymphoma - Doctor's Guide, 9/13/04
- Rituximab Plus CHOP Improves Outcomes in Young, Low-risk Patients With Non-Hodgkin's Lymphoma - Doctor's Guide, 9/13/04
- Addition of Rituximab to Standard Chemotherapy Regimen Improves Survival in Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 9/13/04
- HuMax-CD4, Treatment for Mycosis Fungoides, Receives FDA Orphan Drug Designation - Doctor's Guide, 8/23/04
- Treatment Strategies in Patients With Cutaneous T-Cell Lymphomas - Doctor's Guide, 7/1/04
- Rituximab, a New Advance in the Treatment of Non-Hodgkin Lymphoma - Doctor's Guide, 7/1/04
- Fludarabine Plus Mitoxantrone With Rituximab May be More Effective Front-Line Treatment for Follicular Lymphoma than CHOP - Doctor's Guide, 6/23/04
- Rituximab Plus Thalidomide Demonstrates Marked Anti-Tumour Activity in Patients With Mantle Cell Lymphoma - Doctor's Guide, 6/23/04
- High Response Rates Seen With Fludarabine, Cyclophosphamide and Mitoxantrone in Previously Untreated Advanced Stage Follicular Lymphoma - Doctor's Guide, 6/15/04
- Rituximab/Thalidomide Combination Appears Safe, Effective in Cases of Relapsed or Refractory Mantel Cell Lymphoma - Doctor's Guide, 6/14/04
- Rituximab Equally Effective in Young and Old Patients With Diffuse Large B-cell Non-Hodgkin Lymphoma - Doctor's Guide, 6/10/04
- Relapsed Lymphoma Patients Respond to Gemcitabine-Based Salvage Regimen - Doctor's Guide, 6/8/04
- More Than Half of High-Risk Lymphoma Patients Treated With Suboptimal Regimens - Doctor's Guide, 6/7/04
- Relapsed Mantle-Cell Lymphoma Responds to Rituximab and Thalidomide Therapy - Doctor's Guide, 6/7/04
- Rituximab Plus CHOP Effective as First Line Therapy for Manatle Cell Lymphoma and as Maintenance Therapy for Indolent Lymphoma - Doctor's Guide, 6/7/04
- Fludarabine/Mitoxantrone Combination Appears Safe, Effective As Frontline and Salvage Treatment for Nongastrointestinal Mucosa-Associated Lymphoid Tissue Lymphoma - Doctor's Guide,
5/27/04
- High Remission Rates Reported in Patients Receiving Campath-1H for Refractory Leukaemic Low-Grade Non-Hodgkin's Lymphoma - Doctor's Guide, 5/6/04
- Pamidronate May Reduce New Vertebral Fractures, Loss of Bone Mineral Density in During Chemotherapy for Malignant Lymphoma - Doctor's Guide, 4/26/04
- Methotrexate Implicated in Lymphoma Development in Patient With Rheumatoid Arthritis - Doctor's Guide, 4/19/04
- Rituximab May Produce Complete Remission of Splenic Marginal Zone Lymphoma When Chemotherapy Gives Partial Response - Doctor's Guide, 4/19/04
- Fludarabine/Mitoxantrone/Dexamethasone Therapy Effective for in Elderly Patients with Advanced, Low-Grade Non-Hodgkin's Lymphomas - Doctor's Guide, 4/15/04
- Salvage Therapy With Rituximab-EPOCH Appears Safe, Effective in Relapsed or Refractory B-Cell Lymphomas - Doctor's Guide, 4/15/04
- Acetaminophen May Increase NHL Risk in Women - Doctor's Guide, 3/31/04
- Thalidomide May Not be Effective As Single-Agent Therapy for Recurrent Non-Hodgkin Lymphoma and Hodgkin Disease - Doctor's Guide, 3/29/04
- High-Dose Chemotherapy Plus Hematopoietic Stem-Cell Infusion Appears More Effective Than Standard Chemotherapy for Aggressive Non-Hodgkin?s Lymphoma - Doctor's Guide, 3/26/04
- High-Dose Chemotherapy With SCT Helpful in Aggressive Lymphoma - Medscape, 3/24/04
- Fine-Needle Cytology With Immunophenotyping Accurate in Diagnosing Lymphomas - Doctor's Guide, 3/23/04
- Extension of Rituximab Treatment May Improve Event-Free Survival in Patients with Follicular Lymphoma - Doctor's Guide, 3/23/04
- Rituximab Use Inserted Into New Lymphoma Guidelines - Doctor's Guide, 3/15/04
- Etoposide Improves Standard Chemotherapy in Patients with Aggressive Non-Hodgkin´s Lymphoma - Doctor's Guide, 3/9/04
- Rituximab Adjunct May Improve Response in Patients with Relapsed Diffuse Large B-cell Lymphoma - Doctor's Guide, 2/11/04
- Interferon-alpha/Isotretinoin Combination Therapy May Have Anti-tumour Activity for Advanced and Refractory Lymphomas - Doctor's Guide, 2/10/04
- Anthracycline-Containing Regimens Recommended as Standard Treatment for Advanced Follicular Lymphoma - Doctor's Guide, 2/4/04
- Clinical Remission Achieved In Case Of Adult T Cell Leukaemia/Lymphoma Using Multiple-Agent Therapy With Denileukin Diftitox - Doctor's Guide, 1/30/04
- Long-Term Efficacy With Cyclophosphamide, Epirubicin, Vincristine and Prednisone for Intermediate or High-Grade Non-Hodgkin's Lymphoma - Doctor's Guide, 1/29/04
- Mitoguazone Added to Low-Dose CHOP is Safe and Effective Treatment for AIDS-Related Non-Hodgkin's Lymphoma - Doctor's Guide, 1/22/04
- 90Y Ibritumomab Tiuxetan Safe and Effective Therapy for Many Types of Non-Hodgkin's Lymphoma - Doctor's Guide, 1/21/04
- Doxorubicin- and Pirarubicin-Based Chemotherapy Regimens Equally Effective in Treating Non-Hodgkin's Lymphoma - Doctor's Guide, 12/23/03
- "Bexxar" Regimen Induces Complete Response in Patients with Follicular Non-Hodgkin's Lymphoma - Doctor's Guide, 12/18/03
- Rituximab Increases Time to Progression for Lymphoma Patients - Doctor's Guide, 12/16/03
- New Analysis Confirms Most Complete Remissions in Follicular non-Hodgkin's Lymphoma Persist for Years Following Single Treatment with Bexxar (Tositumomab and Iodine I 131 Tositumomab)
- Doctor's Guide, 12/15/03
- Rituximab Prolongs Chemo Response in Non-Hodgkin's Lymphoma - Doctor's Guide, 12/11/03
- First Line Intensive Chemotherapy Followed by Transplantation May Improve Survival Chances of Patients With High Risk Follicular Lymphoma - Doctor's Guide, 12/10/03
- Treatment With Autologous Stem-Cell Rescue In Peripheral T-Cell Lymphoma Offers Results Similar To B-Cell Lymphoma - Doctor's Guide, 12/10/03
- Rituximab Increases Time to Progression for Lymphoma Patients - Medscape, 12/9/03
- Registry Demonstrates Benefit of Added Rituximab for Diffuse Large B-Cell Lymphoma - Doctor's Guide, 12/9/03
- Fludarabine May Place Patients At Risk Of Hepatitis B From Virus Reactivation - Doctor's Guide, 12/4/03
- Comparable Survival Between Surgery and Surgery Plus Chemotherapy for Localised Gastric Diffuse Large B-Cell Lymphomas - Doctor's Guide, 12/3/03
- Methotrexate Induction Therapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue May Cause Less Neurotoxicity for Primary CNS Lymphoma Patients - Doctor's Guide,
11/27/03
- Combination Cyclophosphamide/Mitoxantrone/Rituximab Regimen Potentially Safe, Effective Therapy for Indolent Lymphoma - Doctor's Guide, 11/14/03
- Improved Response with Rituximab Use in Patients with Non-Hodgkin's Lymphoma - Doctor's Guide, 11/3/03
- Combination of Platinum Derived Chemotherapy and Rituximab Demonstrates Significant Activity in Diffuse Large B-Cell Lymphoma Patients - Doctor's Guide, 10/31/03
- Addition of Rituximab to Chemotherapy Regimen May Increase Complete Remission Rate in Patients With Diffuse Large B-Cell Lymphoma - Doctor's Guide, 10/23/03
- Routine Evaluation of the Stomach Recommended for Mucosa-Associated Lymphoid Tissue Lymphoma Patients - Doctor's Guide, 10/1/03
- Expert Overview of Gastrointestinal Lymphoma - Doctor's Guide, 9/29/03
- Epoetin Beta Treatment During Aggressive Sequential Salvage Chemotherapy Lowers Transfusion Needs, Raises Haemoglobin in Relapsed Lymphoma Patients - Doctor's Guide, 8/27/03
- Phase II Results Demonstrate Long Lasting Tumour Responses For Pixantrone (BBR 2778) In Relapsed Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 8/26/03
- Rituximab May Offer Effective Treatment for Low Grade Duodenal Lymphoma - Doctor's Guide, 8/22/03
- Combination Rituximab, Granulocyte-Colony Stimulating Factor Therapy May Extend Remission Duration In Non-Hodgkin's Lymphoma - Doctor's Guide, 8/18/03
- Delaying Chemotherapy Until Disease Progression Does Not Alter Overall Survival in Advanced-Stage Non-Hodgkin Lymphoma - Doctor's Guide, 8/18/03
- CHOP Superior to CNOP in Elderly Patients With Aggressive Non-Hodgkin Lymphoma - Doctor's Guide, 8/5/03
- Chemotherapy Alone Reduces Delayed Toxicity Risk On Elderly CNS Lymphoma Patients - Doctor's Guide, 7/31/03
- Response to Rituximab Predicted by Polymorphism - Doctor's Guide, 7/15/03
- FDA Approves Bexxar (Tositumomab/Iodine I 131 Tositumomab) For Use In Treatment-Resistant Cancer Of The Lymphatic System - Doctor's Guide, 7/3/03
- High-Dose Methotrexate, Lower-Dose Radiation May Benefit Patients With Primary Central Nervous System Lymphoma - Doctor's Guide, 7/2/03
- Serum Selenium Concentration Predicts Prognosis In Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 7/2/03
- FDA Approves Bexxar in Patients With Follicular Non-Hodgkin's Lymphoma - Doctor's Guide, 6/30/03
- Haematopoietic Stem Cell Transplant Should Not Be First-Line Therapy for Non-Hodgkin's Lymphoma - Doctor's Guide, 6/25/03
- Baseline Anaemia, Older Age Increase Risk of in Non-Hodgkin's Lymphoma - Doctor's Guide, 6/19/03
- Low White Blood Cell Count and Refractory Disease Are Predictive of Poor Response to Mobilisation in Lymphoma - Doctor's Guide, 6/18/03
- Darbepoetin alfa (Aranesp) Treats Chemotherapy-induced Anaemia in Lymphatic Cancers - Doctor's Guide, 6/16/03
- Combined Modality Therapy Continues To Confer High Rates Of Disease Control, Survival For Stage I-II Indolent Non-Hodgkin's Lymphoma - Doctor's Guide, 6/16/03
- Combined Modality Treatment Significantly Increases Survival Rate of Primary Lymphoma Of Bone - Doctor's Guide, 6/6/03
- CNOP Plus Rituximab Safe, Effective In Indolent Non-Hodgkin's Lymphoma - Doctor's Guide, 6/5/03
- Zevalin (Yttrium90-Iribitumomab Tiuxetan) Shows Long-Term Efficacy in Non-Hodgkin's Lymphoma - Doctor's Guide, 6/3/03
- Long-Term Survival For Aggressive Non-Hodgkin's Lymphoma Patients Improved With MabThera Plus Chemotherapy - Doctor's Guide, 6/2/03
- Long-Term Survival Can Be Improved Without Cyclophosphamide For Localised B-Cell Non-Hodgkin's Lymphoma - Doctor's Guide, 5/28/03
- Radioimmunotherapy May Be Safe, Effective Alternative To Treat Advanced Follicular Non-Hodgkin's Lymphoma - Doctor's Guide, 5/28/03
- Prognostic Factors Identify Children With Hodgkin's Disease At High-Risk Of Relapse After Combined-Modality Therapy - Doctor's Guide, 5/27/03
- Fludarabine/Mitoxantrone Combo Safe And Effective For Advanced-Stage, Low-Grade Lymphoma - Doctor's Guide, 5/26/03
- First-Line, Maintenance Rituximab Therapy Effective And Safe In Chronic Lymphocytic Leukaemia Or Small Lymphocytic Lymphoma Patients - Doctor's Guide, 5/21/03
- Prognostic Factors, Treatment for Children with Primary Mediastinal Large B-Cell Lymphoma With Sclerosis - Doctor's Guide, 5/20/03
- Hypothyroidism Linked To Bexarotene For Lymphoma - Doctor's Guide, 4/22/03
- Long-Term Remission Achieved In Mantle-Cell Lymphoma - Doctor's Guide, 4/4/03
- High Dose Methotrexate Has Modest Toxicity Among CNS Lymphoma Cohort - Doctor's Guide, 3/26/03
- Factors That Predict Survival Identified In Localized Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 2/25/03
- Pegfilgrastim Given Once Per Cycle Best After Lymphoma Chemotherapy - Medscape, 2/20/03
- New B-ALPS Prognostic Index Useful In Head And Neck Lymphomas - Doctor's Guide, 1/7/03
- Bexxar (Tositumomab/Iodine I 131 Tositumomab) Receives Strong Support From FDA Advisory Panel - Doctor's Guide, 12/18/02
- Durable Responses With Bexxar (Tositumomab) In Transformed Non Hodgkin's Lymphoma - Doctor's Guide, 12/16/02
- Prolonged Rituximab Treatment Improves Event-Free Survival and Response Duration in Follicular Lymphoma - Doctor's Guide, 12/13/02
- Long-Term Survival Good with Chemotherapy Plus Low-Dose Extended-Field Irradiation - Doctor's Guide, 12/11/02
- Addition of Rituximab to Combination Chemotherapy Significantly Improves Treatment of Mantle Cell Lymphomas - Doctor's Guide, 12/10/02
- Rituximab Improves Responses in Elderly Patients with Advanced Follicular Lymphoma - Doctor's Guide, 12/9/02
- Durable Responses Reported with Single Dose of Tositumomab and Iodine I-131 Tositumomab (Bexxar) in Relapsed, Refractory Low-grade Non-Hodgkin's Lymphoma - Doctor's Guide, 12/9/02
- Rasburicase Reduces Uric Acid Levels in Aggressive Lymphoma Patients - Doctor's Guide, 12/9/02
- Chemotherapy or Chemotherapy/Radiotherapy for Primary Bone Lymphomas - Doctor's Guide, 11/5/02
- Bexarotene Effective For Treatment Of Cutaneous T-Cell Lymphoma - Doctor's Guide, 11/1/02
- Rituximab Effective in Indolent Non-Hodgkin's Lymphoma - Medscape, 10/30/02
- New Diagnostic Tool For T-Cell Lymphoma Faster, More Sensitive - Doctor's Guide, 10/14/02
- Combined Immunomodulatory Therapy Benefits Patients With Cutaneous T-Cell Lymphoma - Doctor's Guide, 9/16/02
- Intrathecal Methotrexate Reduces Recurrence in NHL - Medscape, 8/2/02
- Tobacco may a be cause of non-Hodgkin's lymphoma - USA Today, 7/29/02
- Sequential Fludarabine And CNOP In Follicular Lymphoma - Doctor's Guide, 7/29/02
- French Researchers Offer New Guidelines for Mantle Cell Lymphoma - Doctor's Guide, 6/21/02
- Two Intensive Chemotherapy Regimens Improve Quality Of Life In Elderly Patients With Diffuse Large Cell Lymphoma - Doctor's Guide, 6/20/02
- Molecular Profiling: Future Aid To Some Lymphoma Patients? - Doctor's Guide, 6/20/02
- Radiotherapy Well Tolerated, Effective against Stage I/II Mucosa-associated Lymphoid Tissue Lymphomas - Doctor's Guide, 6/20/02
- Combination of Fludarabine and CVP Effective in Elderly Patients with Advanced Low-Grade Lymphomas - Doctor's Guide, 6/20/02
- Improved Timing Reduces Risks of Involved-Field Radiotherapy in Lymphoma Patients - Doctor's Guide, 6/19/02
- High-Dose Chemotherapy plus Autologous Stem Cell Transplantation no Better than Intensified Chemotherapy against Diffuse Large Cell Lymphoma - Doctor's Guide, 6/19/02
- ACVBP Superior to CHOP plus Radiotherapy in Low-Risk Localized Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 6/19/02
- Dose-Escalated CHOP Therapy plus Etoposide Effective against Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 6/19/02
- Bexxar Found to be Effective against Follicular Lymphoma - Doctor's Guide, 6/19/02
- High-Dose Radioimmunotherapy Best for Mantle Cell Lymphoma - Medscape, 6/18/02
- Quantification of Circulating t(14;18)+ Cells Predicts Response to Rituximab Therapy in Follicular Lymphoma Patients - Doctor's Guide, 6/18/02
- Effect of Rituximab May Be Augmented by Interferon Alfa-2a in Indolent Lymphomas - Doctor's Guide, 6/18/02
- Fludarabine, Cyclophosphamide and Mitoxantrone Safe and Effective against Follicular Lymphoma - Doctor's Guide, 6/18/02
- Modified Chemotherapy Regimen with Mitozantrone Safe and Effective in Elderly Patients with Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 6/18/02
- Bendamustine Better than Cyclophosphamide in Advanced Low Grade Non-Hodgkin's Lymphomas - Doctor's Guide, 6/16/02
- Prognostic Factors for Relapse and Transformation of Indolent Follicular Lymphoma - Doctor's Guide, 6/16/02
- New Evidence that Rituximab May Delay Relapse in Lymphatic Cancer - Doctor's Guide, 6/16/02
- Extended Rituximab Treatment Shows Promise in Waldenström's Macroglobulinemia - Doctor's Guide, 6/13/02
- Ibritumomab Tiuxetan Safe and Effective in Transformed B-cell Non-Hodgkin's Lymphoma - Doctor's Guide, 5/23/02
- Rituximab Subsequent to Zevalin Viable Treatment for Non-Hodgkin's Lymphoma - Doctor's Guide, 5/23/02
- Zevalin Helpful in Low-Grade B-Cell Non-Hodgkin's Lymphoma - Medscape, 5/20/02
- New Radioimmunotherapy Drug Proves Highly Effective For Killing Off B Cell Non-Hodgkin's Lymphoma - Doctor's Guide, 5/13/02
- High-Dose Total Body Radiotherapy with Stem Cell Transplantation Is Effective Treatment for Some Patients with Chemo-Resistant Lymphoma - Doctor's Guide, 5/2/02
- Irradiation of Intraocular Lymphoma Urged in Patients With Primary CNS Lymphomas and Ocular Disease - Doctor's Guide, 4/29/02
- Fewer Than Half Of Mucosa-Associated Lymphoid Tissue Lymphoma Patients Stay In Molecular Remission Following Anti-H Pylori Therapy - Doctor's Guide, 4/11/02
- Significant Association Found With Simian Virus 40 And Non-Hodgkin Lymphoma - Doctor's Guide, 3/12/02
- Mucus In Hair May Indicate Lymphoma - Doctor's Guide, 3/8/02
- Follicular Mycosis Fungoides Is A Distinct Type Of Cutaneous T Cell Lymphoma - Doctor's Guide, 2/26/02
- Bexarotene Gel Safe And Effective For Early-Stage Cutaneous T-Cell Lymphoma - Doctor's Guide, 2/25/02
- FDA Approves Zevalin (ibritumomab tiuxetan) for Treatment of Non-Hodgkin's Lymphoma - Doctor's Guide, 2/20/02
- FDA Approves Anti-Cancer Cell Drug [Zevalin] - Intelihealth, 2/20/02
- More on Epstein-Barr Virus in Hodgkin's Lymphoma - Medscape, 2/02
- Rituxan (Rituximab) plus Standard Chemotherapy Proves More Effective Than Standard Chemo Alone in Aggressive Non-Hodgkin’s Lymphoma - Doctor's Guide, 1/31/02
- New Drug Mix A Significant Advance For Older Lymphoma Patients - Doctor's Guide, 1/25/02
- Fludarabine and Mitoxantrone Followed by Rituximab Demonstrate Efficacy as First-Line Treatment for Follicular Lymphoma - Doctor's Guide, 12/12/01
- CHOP Plus Rituximab Increases Disease-Free Survival Interval in Newly Diagnosed Follicular Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/12/01
- Bexxar Antibody Treatment Increases Response Rate in Refractory or Relapsed Low-Grade Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/12/01
- Bexxar (Tositumomab and Iodine (I)-131-Tositumomab) Plus CHOP Improves Best Result in Newly Diagnosed Follicular Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/12/01
- Long-Term Data Still Favour CHOP + Radiation Therapy for Low Risk Aggressive Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/11/01
- Bexxar (Tositumomab/Iodine I 131 Tositumomab) Promising In Treatment Of Non-Hodgkin's Lymphoma - Doctor's Guide, 12/11/01
- Rituximab Plus CHOP Has Advantage Versus CHOP Alone in Elderly Patients with Diffuse Large B-cell Lymphoma - Doctor's Guide, 12/11/01
- Adding Etoposide to CHOP Improves Results in Younger Low-Risk Non-Hodgkin’s Lymphoma Patients - Doctor's Guide, 12/11/01
- Sequential Fludarabine Followed by CNOP Reduces Toxicity and Maintains Activity in Low-Grade Follicular Lymphoma - Doctor's Guide, 12/11/00
- High Response Rates Seen in Advanced Non-Hodgkin’s Lymphoma Following Consolidation with Rituximab - Doctor's Guide, 12/11/01
- Intensified Biweekly CHOP Chemotherapy Proves Highly Effective In Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 12/10/01
- Mega-CHOP Safe and Effective for Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 12/10/01
- Rituximab Improves Response Rates in Relapsed or Refractory B-Cell Lymphoma - Doctor's Guide, 12/10/01
- Dexamethasone, Cytarabine And Oxaliplatin Salvage Therapy For Non-Hodgkin's Lymphoma - Doctor's Guide, 11/12/01
- Radiation Doesn't Help Hodgkin's Lymphoma Patients Who Are In Remission - Doctor's Guide, 11/6/01
- Experimental Histone Deacetylase Inhibitor Appears Effective In T-Cell Lymphomas - Doctor's Guide, 11/1/01
- Bexxar (Tositumomab/Iodine I 131Tositumomab) Demonstrates Improved Response in Chemo-Refractory Non-Hodgkin's Lymphoma - Doctor's Guide, 10/2/01
- BBR 2778 Shows Promise In Non-Hodgkin's Lymphoma - Doctor's Guide, 10/1/01
- Severe psoriasis linked to lymphoma, skin cancer - USA Today, 6/14/01
- Patient-Optimized Dosing With Bexxar (Tositumomab and Iodine I-131 Tositumomab) Reduces Risk Of Over-/Under-Dosing In Non-Hodgkin's Lymphoma - Doctor's Guide, 5/15/01
- Rituximab Therapy Induces Complete Remissions In Post-Transplant Lymphoproliferative Disorders - Doctor's Guide, 5/15/01
- MabThera (Rituximab) Plus Standard Chemotherapy Improves Survival Rates in Non-Hodgkin’s Lymphoma - Doctor's Guide, 5/14/01
- Anti-CD20 Antibody Rituximab May Have A Role In Primary Central Nervous System Lymphoma Treatment - Doctor's Guide, 4/24/01
- MabThera (Rituximab) With Stem Cell And Bone Marrow Transplant Improves Outcome In Non-Hodgkin’s Lymphoma - Doctor's Guide, 3/26/01
- Anti-Apoptosis Proteins May Predict Prognosis Of Primary CNS Lymphoma - Doctor's Guide, 3/6/01
- Alternative High-Dose Preparatives Needed For Non-Hodgkin's Lymphoma - Doctor's Guide, 2/2/01
- Zevalin (Ibritumomab Tiuxetan) Improves Efficacy Of Rituxan (Rituxumab) In Non-Hodgkin's Lymphoma - Doctor's Guide, 12/5/00
- Mitoxantrone/Fludarabine Followed By Rituximab Effective In Low-Grade Non-Hodgkin's Lymphoma - Doctor's Guide, 12/5/00
- Recombinant Tumor-Derived Protein Stimulates Specific Immune-Response Against Non-Hodgkin's Lymphoma - Doctor's Guide, 12/5/00
- Drug combination improves lymphoma survival rates - CNN, 12/4/00
- Low-dose Radiotherapy Successful For Mucosa-associated Lymphoid-tissue Lymphomas - Doctor's Guide, 10/26/00
- Rituximab Promising In Relapsed Non-Hodgkin’s Lymphoma After Autologous Stem-Cell Transplantation - Doctor's Guide, 7/18/00
- New Combination Effective For Non-Hodgkin's Lymphoma - Doctor's Guide, 7/18/00
- New Treatment Strategies Available For Hodgkin’s Disease And Non-Hodgkin’s Lymphoma - Doctor's Guide, 7/17/00
- Epratuzumab Promising Against Non-Hodgkin's Lymphoma - Doctor's Guide, 5/23/00
- Bexxar Highly Effective First-Line Treatment for Non-Hodgkin's Lymphoma - Doctor's Guide, 5/23/00
- Antibodies Show Promise Vs. Cancer - Intelihealth, 5/23/00
- Antisense drug G3139 for non-Hodgkin's lymphoma reduces target protein levels - Doctor's Guide, 5/5/00
- Onco TCS Shrinks Lymphoma Tumors By At Least 50 Percent In Non-Hodgkin’s Lymphoma Relapses - Doctor's Guide, 12/6/99
- Rituxan, In Combination, Appears Effective For Non-Hodgkin's Lymphoma - Doctor's Guide, 12/6/99
- Bexxar Effective As Combination Therapy For Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/6/99
- Bexxar Halts Progression Of Non-Hodgkin's Lymphoma, Study Shows - Doctor's Guide, 6/7/99
- Rituxan And Fludarabine Effective For NHL Treatment - Doctor's Guide, 5/19/99
- FDA Approves Ontak For Cutaneous T-Cell Lymphoma - Doctor's Guide, 2/5/99
- New Treatment Combo For Non-Hodgkin's Lymphoma - Doctor's Guide, 1/15/99
- Coulter Initiates Expanded Access Program For Bexxar For Non-Hodgkin’s Lymphoma - Doctor's Guide, 9/29/98
- Immunosuppressive Treatment May Help Rheumatoid Arthritis Patients Avoid Lymphomas - Doctor's Guide, 7/17/98
- Some Cancers Come Back Because Chemo Is Stopped Too Soon, Say Researchers - Doctor's Guide, 6/8/98
- First New Drug for Non-Hodgkin's Lymphoma in Decade Cleared In U.S. - Doctor's Guide, 11/26/97
- FDA Clears Intron A For Non-Hodgkin's Lymphoma - Doctor's Guide, 11/10/97
- PCB Exposure May Increase Lymphoma Risk - Doctor's Guide, 7/25/97
- Antibodies May Help Fight Treatment Resistant Non-Hodgkin's Lymphoma - Doctor's Guide, 6/4/97
- Bexxar Effective As First-Line Therapy For Non-Hodgkin's Lymphoma - Doctor's Guide, 5/20/97
Related Searches:
Related Sites:
71129
|
